Acute Ischemic Stroke, Endovascular Treatment, Thrombolysis
Conditions
Brief summary
Objective: To observe the practical application of the standardized green channel treatment system for stroke in Xi 'an in the real world. Methods: Clinical data and information of patients with acute ischemic stroke who received standardized green channel treatment for stroke were collected, and a multicenter observational clinical study was carried out in the real world to evaluate the prognosis, mortality, incidence of asymptomatic and symptomatic cerebral hemorrhage, incidence of pneumonia, and recurrence rate of stroke after 90 days.
Detailed description
The standardized green channel treatment system for acute ischemic stroke includes: Triage nurse triage timely, rapid assessment emergency doctor, suspected stroke the green channel, immediately start in the green channel of stroke accompanied by doctors and nurses stroke patients improve CT examination, intravenous thrombolysis or CT room, emergency room if considering large vascular lesions and the onset time in 6 hours, and rapidly to international for endovascular treatment, if the onset time of more than 6 hours, Rapid evaluation of ischemic penumbra and vascular occlusion by multi-mode imaging. If there are indications for endovascular treatment, go to the cath room for endovascular treatment as soon as possible.
Interventions
OTHERStandardized green channel treatment methods for stroke
The measures include six measures: timely triage by triage desk nurses; Rapid evaluation by emergency room physician; If stroke is suspected, the green channel for nosocomial stroke should be activated immediately. Stroke greenway doctors and stroke nurses accompanied patients to complete CT examination; Intravenous thrombolysis in emergency rooms or CT rooms; Suspected macrovascular disease, if the onset time is less than 6 hours, quickly go to the catheter room for intravascular treatment; If the onset time was more than 6 hours, multi-mode imaging was used to quickly evaluate the ischemic penumbra and vascular occlusion, and then the patients were sent to the catheter room for intravascular treatment as soon as possible.
Sponsors
Xi'an No.3 Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No
Inclusion criteria
* 18 years old; * Consistent with the diagnosis of acute ischemic stroke; * 24 hours from onset to enrollment; * Informed consent
Exclusion criteria
* Patients who refuse to receive intravenous thrombolysis or intravascular intervention (including intravascular mechanical thrombolysis and arterial thrombolysis); * Stroke patients caused by brain tumor, brain trauma and blood diseases; * Those with a history of stroke and sequelae affecting the outcome assessment, namely, mRS 2 points before the onset of this stroke; * Combined with claudication osteoarthritis rheumatoid arthritis gout arthritis and other limb dysfunction and affect the neurological function examination; * Patients with severe hepatic and renal insufficiency (Note: Hepatic insufficiency refers to ALT or AST values greater than 2 times the upper normal limit; Renal insufficiency refers to blood creatinine value greater than 2 times the normal upper limit); * Suffering from other serious life-threatening diseases with an expected survival time of less than 3 months; * Other diseases that limit neurological function evaluation or affect patient follow-up; * A woman planning to be pregnant or breastfeeding; * Currently participating in other clinical trials; * Refuse to participate in the registration of investigators
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Rate of function independent | 90 days after onset | Rate of modified Rankin Scale(mRS) score less than 3 at 90 days |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Rate of mortality | 90 days after onset | 90-day mortality rate |
| Rate of stroke recurrence | 90 days after onset | 90-day stroke recurrence rate |
| Rate of cerebral hemorrhage and pneumonia | During hospitalization. | Incidence of cerebral hemorrhage and pneumonia after thrombolysis or intravascular therapy |
Countries
China
Contacts
Primary ContactMingze Chang, Doctor
Outcome results
None listed